First Horizon Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.6K | Buy |
1,542
+971
| +170% | +$8.59K | ﹤0.01% | 1562 |
|
|
2025
Q1 | $4.47K | Buy |
571
+211
| +59% | +$1.65K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $3.78K | Buy |
360
+253
| +236% | +$2.66K | ﹤0.01% | 1865 |
|
|
2024
Q3 | $1.4K | Sell |
107
-62
| -37% | -$813 | ﹤0.01% | 2084 |
|
|
2024
Q2 | $2.38K | Sell |
169
-42
| -20% | -$590 | ﹤0.01% | 1937 |
|
|
2024
Q1 | $3.56K | Buy |
+211
| New | +$3.56K | ﹤0.01% | 1892 |
|
|
2019
Q4 | – | Sell |
-31
| Closed | – | – | 1511 |
|
|
2019
Q3 | $0 | Hold |
31
| – | – | ﹤0.01% | 1529 |
|
|
2019
Q2 | $0 | Hold |
31
| – | – | ﹤0.01% | 1553 |
|
|
2019
Q1 | $0 | Hold |
31
| – | – | ﹤0.01% | 1557 |
|
|
2018
Q4 | $0 | Hold |
31
| – | – | ﹤0.01% | 1498 |
|
|
2018
Q3 | $0 | Hold |
31
| – | – | ﹤0.01% | 1527 |
|
|
2018
Q2 | $0 | Hold |
31
| – | – | ﹤0.01% | 1534 |
|
|
2018
Q1 | $0 | Hold |
31
| – | – | ﹤0.01% | 1425 |
|
|
2017
Q4 | $0 | Sell |
31
-3
| -9% | – | ﹤0.01% | 1440 |
|
|
2017
Q3 | $0 | Hold |
34
| – | – | ﹤0.01% | 1392 |
|
|
2017
Q2 | $0 | Sell |
34
-1
| -3% | – | ﹤0.01% | 1401 |
|
|
2017
Q1 | $0 | Buy |
35
+20
| +133% | – | ﹤0.01% | 1477 |
|
|
2016
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 1435 |
|
|
2016
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 1431 |
|
|
2016
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 1325 |
|
|
2016
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 1324 |
|
|
2015
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 1258 |
|
|
2015
Q3 | $0 | Buy |
+15
| New | – | ﹤0.01% | 1390 |
|